Literature DB >> 17062728

The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling.

Alberto Bosque1, Juan Ignacio Aguiló, M Angeles Alava, Estela Paz-Artal, Javier Naval, Luis M Allende, Alberto Anel.   

Abstract

The BH3-only protein Bim is required for maintaining the homeostasis of the immune system, since Bim regulates the down-modulation of T-cell responses, mainly through cytokine deprivation. Using T-cell blasts from healthy donors and also from patients with autoimmune lymphoproliferative syndromes (ALPSs) due to homozygous loss-of-function mutation of FasL (ALPS-Ic) or heterozygous mutation in the Fas/CD95 death domain (ALPS-Ia), it is shown that the induction of Bim expression during the process of human T-cell blast generation is strictly dependent on FasL/Fas-mediated signaling. The main pathway by which Fas signaling regulates the levels of Bim expression in human T-cell blasts is the death-domain- and caspase-independent generation of discrete levels of H2O2, which results in the net increase of Foxo3a levels. The present results connect the 2 main pathways described until the moment for the control of T-cell responses: death receptor-mediated activation-induced cell death and apoptosis by cytokine deprivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062728     DOI: 10.1182/blood-2006-05-022319

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory.

Authors:  Sergey A Trushin; Alberto A Carena; Gary D Bren; Stacey A Rizza; Xiangyang Dong; Roshini S Abraham; Andrew D Badley
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

Review 3.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

4.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Authors:  Raif S Geha; Luigi D Notarangelo; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Alain Fischer; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Jennifer M Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2007-10       Impact factor: 10.793

Review 5.  A fork in the path: Developing therapeutic inroads with FoxO proteins.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Jul-Aug       Impact factor: 6.543

Review 6.  FOXO transcription factors throughout T cell biology.

Authors:  Stephen M Hedrick; Rodrigo Hess Michelini; Andrew L Doedens; Ananda W Goldrath; Erica L Stone
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

7.  Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.

Authors:  Raquel Ruiz-García; Sergio Mora; Gema Lozano-Sánchez; Luis Martínez-Lostao; Estela Paz-Artal; Jesús Ruiz-Contreras; Alberto Anel; Luis I González-Granado; David Moreno-Pérez; Luis M Allende
Journal:  Pediatr Res       Date:  2015-09-03       Impact factor: 3.756

Review 8.  OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Trends Mol Med       Date:  2008-04-09       Impact factor: 11.951

Review 9.  Oxidative stress: Biomarkers and novel therapeutic pathways.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.